nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—CYP2A6—Fluorouracil—head and neck cancer	0.156	0.236	CbGbCtD
Selegiline—CYP2D6—Hydroxyurea—head and neck cancer	0.128	0.194	CbGbCtD
Selegiline—CYP2C8—Fluorouracil—head and neck cancer	0.0767	0.116	CbGbCtD
Selegiline—CYP1A2—Fluorouracil—head and neck cancer	0.0594	0.0901	CbGbCtD
Selegiline—CYP2C9—Fluorouracil—head and neck cancer	0.0535	0.0812	CbGbCtD
Selegiline—ABCB1—Vinblastine—head and neck cancer	0.0481	0.073	CbGbCtD
Selegiline—CYP2D6—Vinblastine—head and neck cancer	0.0453	0.0688	CbGbCtD
Selegiline—ABCB1—Docetaxel—head and neck cancer	0.0397	0.0602	CbGbCtD
Selegiline—CYP3A4—Vinblastine—head and neck cancer	0.0288	0.0437	CbGbCtD
Selegiline—CYP3A4—Docetaxel—head and neck cancer	0.0238	0.0361	CbGbCtD
Selegiline—Pseudoephedrine—IL2—head and neck cancer	0.0042	0.793	CrCbGaD
Selegiline—Benzyl alcohol—CYP1A1—head and neck cancer	0.0011	0.207	CrCbGaD
Selegiline—Depression—Vinblastine—head and neck cancer	0.00104	0.00405	CcSEcCtD
Selegiline—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00103	0.004	CcSEcCtD
Selegiline—Myocardial infarction—Vinblastine—head and neck cancer	0.00102	0.00398	CcSEcCtD
Selegiline—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00102	0.00398	CcSEcCtD
Selegiline—Photosensitivity—Fluorouracil—head and neck cancer	0.00101	0.00394	CcSEcCtD
Selegiline—Amenorrhoea—Docetaxel—head and neck cancer	0.001	0.00391	CcSEcCtD
Selegiline—Dysuria—Hydroxyurea—head and neck cancer	0.000996	0.00388	CcSEcCtD
Selegiline—Disorientation—Fluorouracil—head and neck cancer	0.000992	0.00386	CcSEcCtD
Selegiline—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.00097	0.00378	CcSEcCtD
Selegiline—Weight increased—Hydroxyurea—head and neck cancer	0.00097	0.00378	CcSEcCtD
Selegiline—Drowsiness—Hydroxyurea—head and neck cancer	0.00095	0.0037	CcSEcCtD
Selegiline—Amnesia—Fluorouracil—head and neck cancer	0.000945	0.00368	CcSEcCtD
Selegiline—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000931	0.00363	CcSEcCtD
Selegiline—Hypoaesthesia—Vinblastine—head and neck cancer	0.000931	0.00362	CcSEcCtD
Selegiline—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000928	0.00362	CcSEcCtD
Selegiline—Pharyngitis—Vinblastine—head and neck cancer	0.000928	0.00361	CcSEcCtD
Selegiline—Stomatitis—Hydroxyurea—head and neck cancer	0.000926	0.00361	CcSEcCtD
Selegiline—Bone pain—Docetaxel—head and neck cancer	0.000921	0.00359	CcSEcCtD
Selegiline—Lethargy—Fluorouracil—head and neck cancer	0.000906	0.00353	CcSEcCtD
Selegiline—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000899	0.0035	CcSEcCtD
Selegiline—Osteoarthritis—Fluorouracil—head and neck cancer	0.000887	0.00346	CcSEcCtD
Selegiline—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000887	0.00346	CcSEcCtD
Selegiline—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.000882	0.00344	CcSEcCtD
Selegiline—Hallucination—Hydroxyurea—head and neck cancer	0.000849	0.0033	CcSEcCtD
Selegiline—Colitis—Docetaxel—head and neck cancer	0.000847	0.0033	CcSEcCtD
Selegiline—Irritability—Fluorouracil—head and neck cancer	0.000847	0.0033	CcSEcCtD
Selegiline—Cardiac arrest—Fluorouracil—head and neck cancer	0.000844	0.00329	CcSEcCtD
Selegiline—Candida infection—Docetaxel—head and neck cancer	0.000842	0.00328	CcSEcCtD
Selegiline—Fluid retention—Docetaxel—head and neck cancer	0.000838	0.00326	CcSEcCtD
Selegiline—Ataxia—Fluorouracil—head and neck cancer	0.000834	0.00325	CcSEcCtD
Selegiline—Neuropathy—Docetaxel—head and neck cancer	0.000828	0.00323	CcSEcCtD
Selegiline—Alopecia—Vinblastine—head and neck cancer	0.000826	0.00322	CcSEcCtD
Selegiline—Dry skin—Fluorouracil—head and neck cancer	0.000813	0.00317	CcSEcCtD
Selegiline—Oesophagitis—Docetaxel—head and neck cancer	0.000806	0.00314	CcSEcCtD
Selegiline—Neoplasm—Docetaxel—head and neck cancer	0.000798	0.00311	CcSEcCtD
Selegiline—Lightheadedness—Docetaxel—head and neck cancer	0.000789	0.00307	CcSEcCtD
Selegiline—Pulmonary oedema—Docetaxel—head and neck cancer	0.000785	0.00306	CcSEcCtD
Selegiline—Muscular weakness—Fluorouracil—head and neck cancer	0.000783	0.00305	CcSEcCtD
Selegiline—Angiopathy—Hydroxyurea—head and neck cancer	0.000774	0.00301	CcSEcCtD
Selegiline—Dysphagia—Fluorouracil—head and neck cancer	0.000767	0.00299	CcSEcCtD
Selegiline—Chills—Hydroxyurea—head and neck cancer	0.000765	0.00298	CcSEcCtD
Selegiline—Eosinophilia—Fluorouracil—head and neck cancer	0.000759	0.00296	CcSEcCtD
Selegiline—Ill-defined disorder—Vinblastine—head and neck cancer	0.000755	0.00294	CcSEcCtD
Selegiline—Alopecia—Hydroxyurea—head and neck cancer	0.000754	0.00294	CcSEcCtD
Selegiline—Anaemia—Vinblastine—head and neck cancer	0.000752	0.00293	CcSEcCtD
Selegiline—Angina pectoris—Fluorouracil—head and neck cancer	0.000747	0.00291	CcSEcCtD
Selegiline—Erythema—Hydroxyurea—head and neck cancer	0.000742	0.00289	CcSEcCtD
Selegiline—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000736	0.00287	CcSEcCtD
Selegiline—Malaise—Vinblastine—head and neck cancer	0.000734	0.00286	CcSEcCtD
Selegiline—Vertigo—Vinblastine—head and neck cancer	0.000731	0.00285	CcSEcCtD
Selegiline—Leukopenia—Vinblastine—head and neck cancer	0.000729	0.00284	CcSEcCtD
Selegiline—Deafness—Docetaxel—head and neck cancer	0.000716	0.00279	CcSEcCtD
Selegiline—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000706	0.00275	CcSEcCtD
Selegiline—Convulsion—Vinblastine—head and neck cancer	0.000705	0.00275	CcSEcCtD
Selegiline—Hypertension—Vinblastine—head and neck cancer	0.000703	0.00274	CcSEcCtD
Selegiline—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.0007	0.00273	CcSEcCtD
Selegiline—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000689	0.00268	CcSEcCtD
Selegiline—Pneumonia—Fluorouracil—head and neck cancer	0.000688	0.00268	CcSEcCtD
Selegiline—Anaemia—Hydroxyurea—head and neck cancer	0.000686	0.00267	CcSEcCtD
Selegiline—Discomfort—Vinblastine—head and neck cancer	0.000685	0.00267	CcSEcCtD
Selegiline—Atrial fibrillation—Docetaxel—head and neck cancer	0.000676	0.00263	CcSEcCtD
Selegiline—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000674	0.00263	CcSEcCtD
Selegiline—Myocardial infarction—Fluorouracil—head and neck cancer	0.00067	0.00261	CcSEcCtD
Selegiline—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00067	0.00261	CcSEcCtD
Selegiline—Dermatitis bullous—Docetaxel—head and neck cancer	0.00067	0.00261	CcSEcCtD
Selegiline—Malaise—Hydroxyurea—head and neck cancer	0.00067	0.00261	CcSEcCtD
Selegiline—Stomatitis—Fluorouracil—head and neck cancer	0.000667	0.0026	CcSEcCtD
Selegiline—Conjunctivitis—Fluorouracil—head and neck cancer	0.000665	0.00259	CcSEcCtD
Selegiline—Urinary tract infection—Fluorouracil—head and neck cancer	0.000665	0.00259	CcSEcCtD
Selegiline—Leukopenia—Hydroxyurea—head and neck cancer	0.000665	0.00259	CcSEcCtD
Selegiline—Lethargy—Docetaxel—head and neck cancer	0.000654	0.00255	CcSEcCtD
Selegiline—Thrombocytopenia—Vinblastine—head and neck cancer	0.000651	0.00253	CcSEcCtD
Selegiline—Epistaxis—Fluorouracil—head and neck cancer	0.000645	0.00251	CcSEcCtD
Selegiline—Convulsion—Hydroxyurea—head and neck cancer	0.000643	0.00251	CcSEcCtD
Selegiline—Hyponatraemia—Docetaxel—head and neck cancer	0.000643	0.0025	CcSEcCtD
Selegiline—Sinusitis—Fluorouracil—head and neck cancer	0.000642	0.0025	CcSEcCtD
Selegiline—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000641	0.00249	CcSEcCtD
Selegiline—Pain in extremity—Docetaxel—head and neck cancer	0.000641	0.00249	CcSEcCtD
Selegiline—Anorexia—Vinblastine—head and neck cancer	0.000633	0.00247	CcSEcCtD
Selegiline—Migraine—Docetaxel—head and neck cancer	0.00063	0.00246	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000628	0.00244	CcSEcCtD
Selegiline—Discomfort—Hydroxyurea—head and neck cancer	0.000625	0.00243	CcSEcCtD
Selegiline—Rhinitis—Fluorouracil—head and neck cancer	0.000615	0.0024	CcSEcCtD
Selegiline—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000611	0.00238	CcSEcCtD
Selegiline—Pharyngitis—Fluorouracil—head and neck cancer	0.000609	0.00237	CcSEcCtD
Selegiline—Oedema—Hydroxyurea—head and neck cancer	0.000606	0.00236	CcSEcCtD
Selegiline—Ataxia—Docetaxel—head and neck cancer	0.000602	0.00235	CcSEcCtD
Selegiline—Infection—Hydroxyurea—head and neck cancer	0.000602	0.00234	CcSEcCtD
Selegiline—Paraesthesia—Vinblastine—head and neck cancer	0.000597	0.00232	CcSEcCtD
Selegiline—Dehydration—Docetaxel—head and neck cancer	0.000596	0.00232	CcSEcCtD
Selegiline—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000594	0.00231	CcSEcCtD
Selegiline—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000593	0.00231	CcSEcCtD
Selegiline—Liver function test abnormal—Docetaxel—head and neck cancer	0.000591	0.0023	CcSEcCtD
Selegiline—Skin disorder—Hydroxyurea—head and neck cancer	0.000589	0.00229	CcSEcCtD
Selegiline—Dry skin—Docetaxel—head and neck cancer	0.000587	0.00229	CcSEcCtD
Selegiline—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000585	0.00228	CcSEcCtD
Selegiline—Anorexia—Hydroxyurea—head and neck cancer	0.000578	0.00225	CcSEcCtD
Selegiline—Decreased appetite—Vinblastine—head and neck cancer	0.000578	0.00225	CcSEcCtD
Selegiline—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000577	0.00225	CcSEcCtD
Selegiline—Cramp muscle—Docetaxel—head and neck cancer	0.000577	0.00225	CcSEcCtD
Selegiline—Constipation—Vinblastine—head and neck cancer	0.000568	0.00221	CcSEcCtD
Selegiline—Pain—Vinblastine—head and neck cancer	0.000568	0.00221	CcSEcCtD
Selegiline—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000565	0.0022	CcSEcCtD
Selegiline—Dysphagia—Docetaxel—head and neck cancer	0.000554	0.00216	CcSEcCtD
Selegiline—Arrhythmia—Fluorouracil—head and neck cancer	0.000548	0.00214	CcSEcCtD
Selegiline—Feeling abnormal—Vinblastine—head and neck cancer	0.000548	0.00213	CcSEcCtD
Selegiline—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000543	0.00212	CcSEcCtD
Selegiline—Alopecia—Fluorouracil—head and neck cancer	0.000542	0.00211	CcSEcCtD
Selegiline—Dyspnoea—Hydroxyurea—head and neck cancer	0.00054	0.0021	CcSEcCtD
Selegiline—Angina pectoris—Docetaxel—head and neck cancer	0.000539	0.0021	CcSEcCtD
Selegiline—Somnolence—Hydroxyurea—head and neck cancer	0.000539	0.0021	CcSEcCtD
Selegiline—Erythema—Fluorouracil—head and neck cancer	0.000534	0.00208	CcSEcCtD
Selegiline—Dyspepsia—Hydroxyurea—head and neck cancer	0.000533	0.00208	CcSEcCtD
Selegiline—Decreased appetite—Hydroxyurea—head and neck cancer	0.000527	0.00205	CcSEcCtD
Selegiline—Abdominal pain—Vinblastine—head and neck cancer	0.000525	0.00205	CcSEcCtD
Selegiline—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000523	0.00204	CcSEcCtD
Selegiline—Fatigue—Hydroxyurea—head and neck cancer	0.000522	0.00203	CcSEcCtD
Selegiline—Pain—Hydroxyurea—head and neck cancer	0.000518	0.00202	CcSEcCtD
Selegiline—Constipation—Hydroxyurea—head and neck cancer	0.000518	0.00202	CcSEcCtD
Selegiline—Weight increased—Docetaxel—head and neck cancer	0.000504	0.00196	CcSEcCtD
Selegiline—Vision blurred—Fluorouracil—head and neck cancer	0.000504	0.00196	CcSEcCtD
Selegiline—Weight decreased—Docetaxel—head and neck cancer	0.000501	0.00195	CcSEcCtD
Selegiline—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000499	0.00194	CcSEcCtD
Selegiline—Pneumonia—Docetaxel—head and neck cancer	0.000496	0.00193	CcSEcCtD
Selegiline—Anaemia—Fluorouracil—head and neck cancer	0.000494	0.00192	CcSEcCtD
Selegiline—Hypersensitivity—Vinblastine—head and neck cancer	0.00049	0.00191	CcSEcCtD
Selegiline—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000487	0.00189	CcSEcCtD
Selegiline—Myocardial infarction—Docetaxel—head and neck cancer	0.000484	0.00188	CcSEcCtD
Selegiline—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000484	0.00188	CcSEcCtD
Selegiline—Stomatitis—Docetaxel—head and neck cancer	0.000481	0.00187	CcSEcCtD
Selegiline—Conjunctivitis—Docetaxel—head and neck cancer	0.00048	0.00187	CcSEcCtD
Selegiline—Body temperature increased—Hydroxyurea—head and neck cancer	0.000479	0.00187	CcSEcCtD
Selegiline—Leukopenia—Fluorouracil—head and neck cancer	0.000478	0.00186	CcSEcCtD
Selegiline—Asthenia—Vinblastine—head and neck cancer	0.000477	0.00186	CcSEcCtD
Selegiline—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000467	0.00182	CcSEcCtD
Selegiline—Epistaxis—Docetaxel—head and neck cancer	0.000466	0.00181	CcSEcCtD
Selegiline—Convulsion—Fluorouracil—head and neck cancer	0.000463	0.0018	CcSEcCtD
Selegiline—Chest pain—Fluorouracil—head and neck cancer	0.000455	0.00177	CcSEcCtD
Selegiline—Myalgia—Fluorouracil—head and neck cancer	0.000455	0.00177	CcSEcCtD
Selegiline—Diarrhoea—Vinblastine—head and neck cancer	0.000455	0.00177	CcSEcCtD
Selegiline—Discomfort—Fluorouracil—head and neck cancer	0.00045	0.00175	CcSEcCtD
Selegiline—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000446	0.00174	CcSEcCtD
Selegiline—Rhinitis—Docetaxel—head and neck cancer	0.000444	0.00173	CcSEcCtD
Selegiline—Hepatitis—Docetaxel—head and neck cancer	0.000443	0.00173	CcSEcCtD
Selegiline—Hypoaesthesia—Docetaxel—head and neck cancer	0.000441	0.00172	CcSEcCtD
Selegiline—Confusional state—Fluorouracil—head and neck cancer	0.00044	0.00171	CcSEcCtD
Selegiline—Pharyngitis—Docetaxel—head and neck cancer	0.00044	0.00171	CcSEcCtD
Selegiline—Dizziness—Vinblastine—head and neck cancer	0.000439	0.00171	CcSEcCtD
Selegiline—Urinary tract disorder—Docetaxel—head and neck cancer	0.000438	0.0017	CcSEcCtD
Selegiline—Oedema peripheral—Docetaxel—head and neck cancer	0.000436	0.0017	CcSEcCtD
Selegiline—Oedema—Fluorouracil—head and neck cancer	0.000436	0.0017	CcSEcCtD
Selegiline—Asthenia—Hydroxyurea—head and neck cancer	0.000435	0.00169	CcSEcCtD
Selegiline—Urethral disorder—Docetaxel—head and neck cancer	0.000434	0.00169	CcSEcCtD
Selegiline—Infection—Fluorouracil—head and neck cancer	0.000433	0.00169	CcSEcCtD
Selegiline—Nervous system disorder—Fluorouracil—head and neck cancer	0.000428	0.00167	CcSEcCtD
Selegiline—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000427	0.00166	CcSEcCtD
Selegiline—Visual impairment—Docetaxel—head and neck cancer	0.000427	0.00166	CcSEcCtD
Selegiline—Tachycardia—Fluorouracil—head and neck cancer	0.000426	0.00166	CcSEcCtD
Selegiline—Vomiting—Vinblastine—head and neck cancer	0.000422	0.00165	CcSEcCtD
Selegiline—Headache—Vinblastine—head and neck cancer	0.000416	0.00162	CcSEcCtD
Selegiline—Anorexia—Fluorouracil—head and neck cancer	0.000416	0.00162	CcSEcCtD
Selegiline—Diarrhoea—Hydroxyurea—head and neck cancer	0.000415	0.00161	CcSEcCtD
Selegiline—Flushing—Docetaxel—head and neck cancer	0.000411	0.0016	CcSEcCtD
Selegiline—Hypotension—Fluorouracil—head and neck cancer	0.000408	0.00159	CcSEcCtD
Selegiline—Angiopathy—Docetaxel—head and neck cancer	0.000402	0.00157	CcSEcCtD
Selegiline—Dizziness—Hydroxyurea—head and neck cancer	0.000401	0.00156	CcSEcCtD
Selegiline—Chills—Docetaxel—head and neck cancer	0.000398	0.00155	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000397	0.00155	CcSEcCtD
Selegiline—Arrhythmia—Docetaxel—head and neck cancer	0.000396	0.00154	CcSEcCtD
Selegiline—Nausea—Vinblastine—head and neck cancer	0.000395	0.00154	CcSEcCtD
Selegiline—Insomnia—Fluorouracil—head and neck cancer	0.000394	0.00154	CcSEcCtD
Selegiline—Paraesthesia—Fluorouracil—head and neck cancer	0.000392	0.00153	CcSEcCtD
Selegiline—Alopecia—Docetaxel—head and neck cancer	0.000392	0.00152	CcSEcCtD
Selegiline—Dyspnoea—Fluorouracil—head and neck cancer	0.000389	0.00151	CcSEcCtD
Selegiline—Mental disorder—Docetaxel—head and neck cancer	0.000388	0.00151	CcSEcCtD
Selegiline—Somnolence—Fluorouracil—head and neck cancer	0.000388	0.00151	CcSEcCtD
Selegiline—Erythema—Docetaxel—head and neck cancer	0.000386	0.0015	CcSEcCtD
Selegiline—Malnutrition—Docetaxel—head and neck cancer	0.000386	0.0015	CcSEcCtD
Selegiline—Vomiting—Hydroxyurea—head and neck cancer	0.000385	0.0015	CcSEcCtD
Selegiline—Dyspepsia—Fluorouracil—head and neck cancer	0.000384	0.0015	CcSEcCtD
Selegiline—Rash—Hydroxyurea—head and neck cancer	0.000382	0.00149	CcSEcCtD
Selegiline—Dermatitis—Hydroxyurea—head and neck cancer	0.000382	0.00149	CcSEcCtD
Selegiline—Headache—Hydroxyurea—head and neck cancer	0.00038	0.00148	CcSEcCtD
Selegiline—Decreased appetite—Fluorouracil—head and neck cancer	0.000379	0.00148	CcSEcCtD
Selegiline—Dysgeusia—Docetaxel—head and neck cancer	0.000378	0.00147	CcSEcCtD
Selegiline—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000377	0.00147	CcSEcCtD
Selegiline—Back pain—Docetaxel—head and neck cancer	0.000373	0.00145	CcSEcCtD
Selegiline—Pain—Fluorouracil—head and neck cancer	0.000373	0.00145	CcSEcCtD
Selegiline—Muscle spasms—Docetaxel—head and neck cancer	0.000371	0.00144	CcSEcCtD
Selegiline—Nausea—Hydroxyurea—head and neck cancer	0.00036	0.0014	CcSEcCtD
Selegiline—Feeling abnormal—Fluorouracil—head and neck cancer	0.000359	0.0014	CcSEcCtD
Selegiline—Anaemia—Docetaxel—head and neck cancer	0.000357	0.00139	CcSEcCtD
Selegiline—Urticaria—Fluorouracil—head and neck cancer	0.000346	0.00135	CcSEcCtD
Selegiline—Syncope—Docetaxel—head and neck cancer	0.000346	0.00135	CcSEcCtD
Selegiline—Leukopenia—Docetaxel—head and neck cancer	0.000345	0.00134	CcSEcCtD
Selegiline—Body temperature increased—Fluorouracil—head and neck cancer	0.000345	0.00134	CcSEcCtD
Selegiline—Palpitations—Docetaxel—head and neck cancer	0.000341	0.00133	CcSEcCtD
Selegiline—Loss of consciousness—Docetaxel—head and neck cancer	0.000339	0.00132	CcSEcCtD
Selegiline—Cough—Docetaxel—head and neck cancer	0.000337	0.00131	CcSEcCtD
Selegiline—Convulsion—Docetaxel—head and neck cancer	0.000334	0.0013	CcSEcCtD
Selegiline—Hypertension—Docetaxel—head and neck cancer	0.000333	0.0013	CcSEcCtD
Selegiline—Arthralgia—Docetaxel—head and neck cancer	0.000328	0.00128	CcSEcCtD
Selegiline—Chest pain—Docetaxel—head and neck cancer	0.000328	0.00128	CcSEcCtD
Selegiline—Myalgia—Docetaxel—head and neck cancer	0.000328	0.00128	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000326	0.00127	CcSEcCtD
Selegiline—Hypersensitivity—Fluorouracil—head and neck cancer	0.000321	0.00125	CcSEcCtD
Selegiline—Dry mouth—Docetaxel—head and neck cancer	0.000321	0.00125	CcSEcCtD
Selegiline—Confusional state—Docetaxel—head and neck cancer	0.000317	0.00124	CcSEcCtD
Selegiline—Oedema—Docetaxel—head and neck cancer	0.000315	0.00123	CcSEcCtD
Selegiline—Infection—Docetaxel—head and neck cancer	0.000313	0.00122	CcSEcCtD
Selegiline—Shock—Docetaxel—head and neck cancer	0.00031	0.00121	CcSEcCtD
Selegiline—Nervous system disorder—Docetaxel—head and neck cancer	0.000309	0.0012	CcSEcCtD
Selegiline—Pruritus—Fluorouracil—head and neck cancer	0.000309	0.0012	CcSEcCtD
Selegiline—Thrombocytopenia—Docetaxel—head and neck cancer	0.000308	0.0012	CcSEcCtD
Selegiline—Tachycardia—Docetaxel—head and neck cancer	0.000307	0.0012	CcSEcCtD
Selegiline—Skin disorder—Docetaxel—head and neck cancer	0.000306	0.00119	CcSEcCtD
Selegiline—Anorexia—Docetaxel—head and neck cancer	0.0003	0.00117	CcSEcCtD
Selegiline—Diarrhoea—Fluorouracil—head and neck cancer	0.000298	0.00116	CcSEcCtD
Selegiline—Hypotension—Docetaxel—head and neck cancer	0.000294	0.00115	CcSEcCtD
Selegiline—Dizziness—Fluorouracil—head and neck cancer	0.000288	0.00112	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000287	0.00112	CcSEcCtD
Selegiline—Insomnia—Docetaxel—head and neck cancer	0.000285	0.00111	CcSEcCtD
Selegiline—Paraesthesia—Docetaxel—head and neck cancer	0.000283	0.0011	CcSEcCtD
Selegiline—Dyspnoea—Docetaxel—head and neck cancer	0.000281	0.00109	CcSEcCtD
Selegiline—Somnolence—Docetaxel—head and neck cancer	0.00028	0.00109	CcSEcCtD
Selegiline—Vomiting—Fluorouracil—head and neck cancer	0.000277	0.00108	CcSEcCtD
Selegiline—Dyspepsia—Docetaxel—head and neck cancer	0.000277	0.00108	CcSEcCtD
Selegiline—Rash—Fluorouracil—head and neck cancer	0.000275	0.00107	CcSEcCtD
Selegiline—Dermatitis—Fluorouracil—head and neck cancer	0.000275	0.00107	CcSEcCtD
Selegiline—Decreased appetite—Docetaxel—head and neck cancer	0.000274	0.00107	CcSEcCtD
Selegiline—Headache—Fluorouracil—head and neck cancer	0.000273	0.00106	CcSEcCtD
Selegiline—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000272	0.00106	CcSEcCtD
Selegiline—Fatigue—Docetaxel—head and neck cancer	0.000271	0.00106	CcSEcCtD
Selegiline—Constipation—Docetaxel—head and neck cancer	0.000269	0.00105	CcSEcCtD
Selegiline—Pain—Docetaxel—head and neck cancer	0.000269	0.00105	CcSEcCtD
Selegiline—Feeling abnormal—Docetaxel—head and neck cancer	0.000259	0.00101	CcSEcCtD
Selegiline—Nausea—Fluorouracil—head and neck cancer	0.000259	0.00101	CcSEcCtD
Selegiline—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000257	0.001	CcSEcCtD
Selegiline—Abdominal pain—Docetaxel—head and neck cancer	0.000249	0.000969	CcSEcCtD
Selegiline—Body temperature increased—Docetaxel—head and neck cancer	0.000249	0.000969	CcSEcCtD
Selegiline—Hypersensitivity—Docetaxel—head and neck cancer	0.000232	0.000903	CcSEcCtD
Selegiline—Asthenia—Docetaxel—head and neck cancer	0.000226	0.00088	CcSEcCtD
Selegiline—Pruritus—Docetaxel—head and neck cancer	0.000223	0.000867	CcSEcCtD
Selegiline—Diarrhoea—Docetaxel—head and neck cancer	0.000215	0.000839	CcSEcCtD
Selegiline—Dizziness—Docetaxel—head and neck cancer	0.000208	0.000811	CcSEcCtD
Selegiline—Vomiting—Docetaxel—head and neck cancer	0.0002	0.00078	CcSEcCtD
Selegiline—Rash—Docetaxel—head and neck cancer	0.000198	0.000773	CcSEcCtD
Selegiline—Dermatitis—Docetaxel—head and neck cancer	0.000198	0.000772	CcSEcCtD
Selegiline—Headache—Docetaxel—head and neck cancer	0.000197	0.000768	CcSEcCtD
Selegiline—Nausea—Docetaxel—head and neck cancer	0.000187	0.000728	CcSEcCtD
Selegiline—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000186	0.00236	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000183	0.00232	CbGpPWpGaD
Selegiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000181	0.00229	CbGpPWpGaD
Selegiline—CYP2A6—Biological oxidations—GSTM1—head and neck cancer	0.000181	0.00229	CbGpPWpGaD
Selegiline—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00018	0.00229	CbGpPWpGaD
Selegiline—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000179	0.00227	CbGpPWpGaD
Selegiline—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000174	0.0022	CbGpPWpGaD
Selegiline—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000173	0.00219	CbGpPWpGaD
Selegiline—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000171	0.00217	CbGpPWpGaD
Selegiline—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	0.000171	0.00217	CbGpPWpGaD
Selegiline—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000167	0.00211	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000167	0.00211	CbGpPWpGaD
Selegiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000153	0.00194	CbGpPWpGaD
Selegiline—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000152	0.00193	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—UROD—head and neck cancer	0.000151	0.00191	CbGpPWpGaD
Selegiline—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000147	0.00186	CbGpPWpGaD
Selegiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000146	0.00185	CbGpPWpGaD
Selegiline—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.000146	0.00185	CbGpPWpGaD
Selegiline—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000144	0.00182	CbGpPWpGaD
Selegiline—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000144	0.00182	CbGpPWpGaD
Selegiline—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	0.000143	0.00181	CbGpPWpGaD
Selegiline—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000141	0.00178	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000139	0.00176	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000139	0.00176	CbGpPWpGaD
Selegiline—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.000138	0.00175	CbGpPWpGaD
Selegiline—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000136	0.00173	CbGpPWpGaD
Selegiline—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	0.000135	0.00172	CbGpPWpGaD
Selegiline—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000134	0.0017	CbGpPWpGaD
Selegiline—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000134	0.00169	CbGpPWpGaD
Selegiline—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000132	0.00168	CbGpPWpGaD
Selegiline—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.00013	0.00165	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000129	0.00163	CbGpPWpGaD
Selegiline—MAOB—Metabolism—NAT2—head and neck cancer	0.000128	0.00163	CbGpPWpGaD
Selegiline—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000123	0.00156	CbGpPWpGaD
Selegiline—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000122	0.00154	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—UROD—head and neck cancer	0.000122	0.00154	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—UROD—head and neck cancer	0.000119	0.00151	CbGpPWpGaD
Selegiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000118	0.0015	CbGpPWpGaD
Selegiline—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.000117	0.00148	CbGpPWpGaD
Selegiline—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000115	0.00146	CbGpPWpGaD
Selegiline—MAOB—Metabolism—DPYD—head and neck cancer	0.000113	0.00143	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000112	0.00142	CbGpPWpGaD
Selegiline—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.00011	0.0014	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000109	0.00139	CbGpPWpGaD
Selegiline—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000109	0.00138	CbGpPWpGaD
Selegiline—MAOB—Metabolism—YAP1—head and neck cancer	0.000107	0.00135	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—IL2—head and neck cancer	0.000105	0.00133	CbGpPWpGaD
Selegiline—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.000104	0.00132	CbGpPWpGaD
Selegiline—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000103	0.00131	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—UROD—head and neck cancer	0.000103	0.0013	CbGpPWpGaD
Selegiline—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000103	0.0013	CbGpPWpGaD
Selegiline—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.000101	0.00128	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000101	0.00127	CbGpPWpGaD
Selegiline—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.0001	0.00127	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.0001	0.00127	CbGpPWpGaD
Selegiline—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	9.99e-05	0.00127	CbGpPWpGaD
Selegiline—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	9.91e-05	0.00126	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	9.86e-05	0.00125	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	9.85e-05	0.00125	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	9.85e-05	0.00125	CbGpPWpGaD
Selegiline—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	9.61e-05	0.00122	CbGpPWpGaD
Selegiline—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	9.52e-05	0.00121	CbGpPWpGaD
Selegiline—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	9.47e-05	0.0012	CbGpPWpGaD
Selegiline—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	9.39e-05	0.00119	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—UROD—head and neck cancer	9.19e-05	0.00116	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—UROD—head and neck cancer	8.97e-05	0.00114	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	8.9e-05	0.00113	CbGpPWpGaD
Selegiline—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	8.58e-05	0.00109	CbGpPWpGaD
Selegiline—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	8.47e-05	0.00107	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—UROD—head and neck cancer	8.45e-05	0.00107	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—UROD—head and neck cancer	8.38e-05	0.00106	CbGpPWpGaD
Selegiline—MAOA—Transmission across Chemical Synapses—MAPK1—head and neck cancer	8.25e-05	0.00104	CbGpPWpGaD
Selegiline—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	8.14e-05	0.00103	CbGpPWpGaD
Selegiline—MAOA—Metabolism—NAT2—head and neck cancer	8.06e-05	0.00102	CbGpPWpGaD
Selegiline—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	8.03e-05	0.00102	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.99e-05	0.00101	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	7.91e-05	0.001	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—UROD—head and neck cancer	7.16e-05	0.000907	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.13e-05	0.000903	CbGpPWpGaD
Selegiline—MAOA—Metabolism—DPYD—head and neck cancer	7.07e-05	0.000896	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	6.84e-05	0.000867	CbGpPWpGaD
Selegiline—MAOA—Metabolism—YAP1—head and neck cancer	6.71e-05	0.00085	CbGpPWpGaD
Selegiline—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	6.63e-05	0.00084	CbGpPWpGaD
Selegiline—MAOA—Transmission across Chemical Synapses—HRAS—head and neck cancer	6.62e-05	0.000839	CbGpPWpGaD
Selegiline—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	6.56e-05	0.000831	CbGpPWpGaD
Selegiline—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	6.53e-05	0.000828	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.5e-05	0.000824	CbGpPWpGaD
Selegiline—MAOB—Metabolism—TYMS—head and neck cancer	6.42e-05	0.000813	CbGpPWpGaD
Selegiline—MAOB—Metabolism—GSTM1—head and neck cancer	6.34e-05	0.000804	CbGpPWpGaD
Selegiline—MAOA—Neuronal System—MAPK1—head and neck cancer	6.32e-05	0.000801	CbGpPWpGaD
Selegiline—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	6.28e-05	0.000796	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—NAT2—head and neck cancer	6.26e-05	0.000793	CbGpPWpGaD
Selegiline—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	6.19e-05	0.000785	CbGpPWpGaD
Selegiline—MAOB—Metabolism—GPX1—head and neck cancer	6.07e-05	0.00077	CbGpPWpGaD
Selegiline—MAOB—Metabolism—CYP1A1—head and neck cancer	6.01e-05	0.000762	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	5.87e-05	0.000744	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	5.57e-05	0.000706	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.55e-05	0.000704	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—UROD—head and neck cancer	5.52e-05	0.0007	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—DPYD—head and neck cancer	5.49e-05	0.000695	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—YAP1—head and neck cancer	5.21e-05	0.00066	CbGpPWpGaD
Selegiline—MAOA—Neuronal System—HRAS—head and neck cancer	5.07e-05	0.000643	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—NAT2—head and neck cancer	5.05e-05	0.00064	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	5.04e-05	0.000638	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—NAT2—head and neck cancer	4.94e-05	0.000627	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	4.86e-05	0.000616	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.54e-05	0.000575	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.49e-05	0.000569	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—DPYD—head and neck cancer	4.43e-05	0.000561	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	4.39e-05	0.000556	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—DPYD—head and neck cancer	4.34e-05	0.000549	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—NAT2—head and neck cancer	4.27e-05	0.000542	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—YAP1—head and neck cancer	4.2e-05	0.000532	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	4.15e-05	0.000526	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—YAP1—head and neck cancer	4.11e-05	0.000521	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.05e-05	0.000513	CbGpPWpGaD
Selegiline—MAOA—Metabolism—TYMS—head and neck cancer	4.03e-05	0.00051	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.01e-05	0.000508	CbGpPWpGaD
Selegiline—MAOA—Metabolism—GSTM1—head and neck cancer	3.98e-05	0.000504	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.95e-05	0.000501	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.95e-05	0.000501	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—NAT2—head and neck cancer	3.81e-05	0.000483	CbGpPWpGaD
Selegiline—MAOA—Metabolism—GPX1—head and neck cancer	3.81e-05	0.000483	CbGpPWpGaD
Selegiline—MAOA—Metabolism—CYP1A1—head and neck cancer	3.77e-05	0.000478	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—DPYD—head and neck cancer	3.75e-05	0.000475	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—NAT2—head and neck cancer	3.72e-05	0.000472	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.69e-05	0.000468	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.66e-05	0.000463	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PTGS2—head and neck cancer	3.58e-05	0.000453	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—YAP1—head and neck cancer	3.56e-05	0.000451	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—NAT2—head and neck cancer	3.51e-05	0.000445	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—NAT2—head and neck cancer	3.48e-05	0.000441	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.43e-05	0.000435	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—DPYD—head and neck cancer	3.35e-05	0.000424	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	3.32e-05	0.00042	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—DPYD—head and neck cancer	3.26e-05	0.000414	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—YAP1—head and neck cancer	3.17e-05	0.000402	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.16e-05	0.0004	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—TYMS—head and neck cancer	3.13e-05	0.000396	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.12e-05	0.000396	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PTEN—head and neck cancer	3.12e-05	0.000395	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—YAP1—head and neck cancer	3.1e-05	0.000393	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—GSTM1—head and neck cancer	3.09e-05	0.000392	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—DPYD—head and neck cancer	3.08e-05	0.00039	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—DPYD—head and neck cancer	3.05e-05	0.000387	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NAT2—head and neck cancer	2.97e-05	0.000377	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—GPX1—head and neck cancer	2.96e-05	0.000375	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CYP1A1—head and neck cancer	2.93e-05	0.000371	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—YAP1—head and neck cancer	2.92e-05	0.00037	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—YAP1—head and neck cancer	2.89e-05	0.000367	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.8e-05	0.000355	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.67e-05	0.000339	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—DPYD—head and neck cancer	2.61e-05	0.00033	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—TYMS—head and neck cancer	2.52e-05	0.00032	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GSTM1—head and neck cancer	2.49e-05	0.000316	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—YAP1—head and neck cancer	2.47e-05	0.000313	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—TYMS—head and neck cancer	2.47e-05	0.000313	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GSTM1—head and neck cancer	2.44e-05	0.000309	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GPX1—head and neck cancer	2.39e-05	0.000303	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.39e-05	0.000302	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYP1A1—head and neck cancer	2.36e-05	0.0003	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GPX1—head and neck cancer	2.34e-05	0.000296	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.33e-05	0.000295	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CYP1A1—head and neck cancer	2.32e-05	0.000293	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NAT2—head and neck cancer	2.29e-05	0.000291	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PTGS2—head and neck cancer	2.24e-05	0.000284	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PIK3CA—head and neck cancer	2.2e-05	0.000279	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.17e-05	0.000276	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—TYMS—head and neck cancer	2.14e-05	0.000271	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GSTM1—head and neck cancer	2.11e-05	0.000267	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.08e-05	0.000264	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GPX1—head and neck cancer	2.02e-05	0.000256	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—DPYD—head and neck cancer	2.01e-05	0.000255	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP1A1—head and neck cancer	2e-05	0.000254	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PTEN—head and neck cancer	1.96e-05	0.000248	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—YAP1—head and neck cancer	1.91e-05	0.000242	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—TYMS—head and neck cancer	1.91e-05	0.000242	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.9e-05	0.00024	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.88e-05	0.000239	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—TYMS—head and neck cancer	1.86e-05	0.000236	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.86e-05	0.000235	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSTM1—head and neck cancer	1.84e-05	0.000233	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GPX1—head and neck cancer	1.8e-05	0.000229	CbGpPWpGaD
Selegiline—MAOB—Metabolism—AKT1—head and neck cancer	1.8e-05	0.000228	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.79e-05	0.000226	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GPX1—head and neck cancer	1.76e-05	0.000223	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—TYMS—head and neck cancer	1.75e-05	0.000222	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.74e-05	0.000221	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PTGS2—head and neck cancer	1.74e-05	0.000221	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—TYMS—head and neck cancer	1.74e-05	0.00022	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.73e-05	0.00022	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.72e-05	0.000218	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GPX1—head and neck cancer	1.66e-05	0.00021	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GPX1—head and neck cancer	1.65e-05	0.000208	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.64e-05	0.000208	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.64e-05	0.000208	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.63e-05	0.000206	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.62e-05	0.000205	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PTEN—head and neck cancer	1.52e-05	0.000193	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—TYMS—head and neck cancer	1.49e-05	0.000188	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.47e-05	0.000186	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.47e-05	0.000186	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GPX1—head and neck cancer	1.41e-05	0.000178	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PTGS2—head and neck cancer	1.41e-05	0.000178	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.39e-05	0.000176	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CA—head and neck cancer	1.38e-05	0.000175	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTGS2—head and neck cancer	1.38e-05	0.000174	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.34e-05	0.00017	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PTEN—head and neck cancer	1.23e-05	0.000155	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTEN—head and neck cancer	1.2e-05	0.000152	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.19e-05	0.000151	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—TYMS—head and neck cancer	1.15e-05	0.000145	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.14e-05	0.000145	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.13e-05	0.000144	CbGpPWpGaD
Selegiline—MAOA—Metabolism—AKT1—head and neck cancer	1.13e-05	0.000143	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GPX1—head and neck cancer	1.09e-05	0.000137	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.07e-05	0.000136	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CA—head and neck cancer	1.07e-05	0.000136	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.06e-05	0.000135	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTEN—head and neck cancer	1.04e-05	0.000132	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTGS2—head and neck cancer	1.04e-05	0.000131	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTGS2—head and neck cancer	9.77e-06	0.000124	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTGS2—head and neck cancer	9.69e-06	0.000123	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTEN—head and neck cancer	9.26e-06	0.000117	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTEN—head and neck cancer	9.04e-06	0.000115	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—AKT1—head and neck cancer	8.76e-06	0.000111	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CA—head and neck cancer	8.65e-06	0.00011	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTEN—head and neck cancer	8.52e-06	0.000108	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CA—head and neck cancer	8.47e-06	0.000107	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTEN—head and neck cancer	8.45e-06	0.000107	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTGS2—head and neck cancer	8.28e-06	0.000105	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CA—head and neck cancer	7.32e-06	9.28e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTEN—head and neck cancer	7.22e-06	9.15e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—AKT1—head and neck cancer	7.06e-06	8.95e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—AKT1—head and neck cancer	6.92e-06	8.77e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CA—head and neck cancer	6.54e-06	8.28e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTGS2—head and neck cancer	6.39e-06	8.09e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CA—head and neck cancer	6.38e-06	8.08e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CA—head and neck cancer	6.01e-06	7.62e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—AKT1—head and neck cancer	5.98e-06	7.58e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CA—head and neck cancer	5.96e-06	7.55e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTEN—head and neck cancer	5.57e-06	7.06e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—AKT1—head and neck cancer	5.34e-06	6.76e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—AKT1—head and neck cancer	5.21e-06	6.6e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CA—head and neck cancer	5.09e-06	6.45e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—AKT1—head and neck cancer	4.91e-06	6.22e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—AKT1—head and neck cancer	4.87e-06	6.17e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—AKT1—head and neck cancer	4.16e-06	5.27e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.93e-06	4.98e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—AKT1—head and neck cancer	3.21e-06	4.07e-05	CbGpPWpGaD
